LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Total liabilities 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) total liabilities at each fiscal year-end, per SEC filings.
$191.9MFY2025 · since FY2016: $130.3M → $191.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $191.9M | -4.1% |
| FY2024 | $200.1M | -8.4% |
| FY2023 | $218.5M | +16.9% |
| FY2022 | $186.9M | -37.7% |
| FY2021 | $299.9M | -3.3% |
| FY2020 | $310.3M | +24.6% |
| FY2019 | $248.9M | +63.6% |
| FY2018 | $152.1M | +16.6% |
| FY2017 | $130.5M | +0.1% |
| FY2016 | $130.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Net marginLFCR Gross profitLFCR Gross marginLFCR Operating incomeLFCR Operating marginLFCR Operating cash flowLFCR Free cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Shareholders’ equityLFCR overview →